June is Myasthenia Gravis Awareness month. We are trying to raise awareness through various activities. One such activity is ...

The FDA has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis in patients aged 12 years and older who are AChR or anti-muscle-specific tyrosine kinase antibody ...

Despite acknowledging that efgartigimod (Vyvgart), can 'improve symptoms and people’s ability to carry out their normal ...